Exome sequencing identifies novel dysferlin mutation in a family with pauci-symptomatic heterozygous carriers

Simple item page
dc.contributor.authorJalali-Sefid-Dashti, Mahjoubeh
dc.contributor.authorNel, Melissa
dc.contributor.authorHeckmann, Jeannine M.
dc.contributor.authorGamieldien, Junaid
dc.date.accessioned2019-10-22T07:35:44Z
dc.date.available2019-10-22T07:35:44Z
dc.date.issued2018
dc.description.abstractBackground: We investigated a South African family of admixed ancestry in which the first generation (G1) developed insidious progressive distal to proximal weakness in their twenties, while their offspring (G2) experienced severe unexpected symptoms of myalgia and cramps since adolescence. Our aim was to identify deleterious mutations that segregate with the affected individuals in this family. Methods: Exome sequencing was performed on five cases, which included three affected G1 siblings and two pauci-symptomatic G2 offspring. As controls we included an unaffected G1 sibling and a spouse of one of the G1 affected individuals. Homozygous or potentially compound heterozygous variants that were predicted to be functional and segregated with the affected G1 siblings, were further evaluated. Additionally, we considered variants in all genes segregating exclusively with the affected (G1) and pauci-symptomatic (G2) individuals to address the possibility of a pseudo-autosomal dominant inheritance pattern in this family. Results: All affected G1 individuals were homozygous for a novel truncating p.Tyr1433Ter DYSF (dysferlin) mutation, with their asymptomatic sibling and both pauci-symptomatic G2 offspring carrying only a single mutant allele. Sanger sequencing confirmed segregation of the variant. No additional potentially contributing variant was found in the DYSF or any other relevant gene in the pauci-symptomatic carriers. Conclusion: Our finding of a truncating dysferlin mutation confirmed dysferlinopathy in this family and we propose that the single mutant allele is the primary contributor to the neuromuscular symptoms seen in the second-generation pauci-symptomatic carriers.en_US
dc.identifier.citationJalali-Sefid-Dashti, M., Nel, M., Heckmann, J., & Gamieldien, J. (2018). Exome sequencing identifies novel dysferlin mutation in a family with pauci-symptomatic heterozygous carriers. BMC Medical Genetics, 19(1). doi: 10.1186/s12881-018-0613-xen_US
dc.identifier.issn1471-2350
dc.identifier.urihttps://doi.org/10.1186/s12881-018-0613-x
dc.identifier.urihttp://hdl.handle.net/10566/5062
dc.language.isoenen_US
dc.publisherSpringer Natureen_US
dc.subjectExomeen_US
dc.subjectDysferlinopathyen_US
dc.subjectMyalgiaen_US
dc.subjectCrampsen_US
dc.subjectPauci-symptomatic carriersen_US
dc.titleExome sequencing identifies novel dysferlin mutation in a family with pauci-symptomatic heterozygous carriersen_US
dc.typeArticleen_US

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
s12881-018-0613-x.pdf
Size:
953.76 KB
Format:
Adobe Portable Document Format
Description:
Jalali-Sefid-Dashti_exome_sequencing_2018
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Research Articles (SANBI)